Principal results of the cancer of the ovary abiraterone trial (CORAL): A phase II study of abiraterone in patients with recurrent epithelial ovarian cancer (CRUKE/12/052)
Journal article published in 2016 by
S. Banerjee 
,
L. Kilburn ,
R. Bowen,
H. Tovey,
M. Hall,
S. Kaye,
G. Rustin,
M. Gore,
J. McLachlan,
A. Attygalle,
N. Tunariu,
J. P. Lima,
P. Chatfield,
L. Jeffs,
E. Folkerd
and other authors.
,
L. Kilburn ,
R. Bowen,
H. Tovey,
M. Hall,
S. Kaye,
G. Rustin,
M. Gore,
J. McLachlan,
A. Attygalle,
N. Tunariu,
J. P. Lima,
P. Chatfield,
L. Jeffs,
E. Folkerd
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 